Clinical Trials Sponsored by BIOrest Ltd.

Total 19723 results

bioRASI, LLC

Completed

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Papulopustular Rosacea | Erythematotelangiectatic Rosacea

United States
BioCryst Pharmaceuticals

Completed

A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

Hereditary Angioedema

United Kingdom
Bioness Inc

Completed

Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy

Chronic Pain

United States
Bioness Inc

Completed

An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects (BBPM)

Shoulder Pain Chronic

United States
BioCryst Pharmaceuticals

Completed

12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks (OPuS-2)

Hereditary Angioedema | HAE

France, United Kingdom, Germany, United States, Belgium, Hungary, Italy, Canada
BioCryst Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza

Influenza

United States, Australia, Canada, Hong Kong, New Zealand, Singapore, South Africa
BioCryst Pharmaceuticals

Completed

A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency

Renal Insufficiency | Arthritis | Hyperuricemia | Gout | Joint Disease

United States
BioCryst Pharmaceuticals

Completed

Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)

Leukemia, Lymphocytic, Chronic

United States
BioCryst Pharmaceuticals

Completed

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL)

United States, Australia
BioCryst Pharmaceuticals

Completed

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

Gout

United States
BioCryst Pharmaceuticals

Completed

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL),

United States, Australia, Germany, Italy, Spain, France, Austria, Finland, Switzerland, United Kingdom
BioCryst Pharmaceuticals

Withdrawn

Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

Influenza
Zimmer Biomet
Biomet Belgium BVBA

Completed

Comparison of ARPE Prosthesis With the Literature

Arthritis

Belgium
Zimmer Biomet
Biomet Japan, Inc.

Completed

Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System

Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement

Japan
Zimmer Biomet
Biomet Biologics, LLC

Completed

Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)

Osteoarthritis, Knee

United States
Biomet Orthopedics, LLC

Completed

A Clinical Investigation of the Balance® Microplasty™ Hip System

Rheumatoid Arthritis | Avascular Necrosis | Osteoarthritis, Hip

United States
Biomet Orthopedics, LLC

Completed

A Clinical Investigation of the C2a-Taper™ Acetabular System

Osteoarthritis | Avascular Necrosis | Congenital Hip Dysplasia | Traumatic Arthritis

United States
Zimmer Biomet
Biomet France SARL

Terminated

ROCC Knee Data Collection

Arthritis of Knee

Spain, Austria, France
Zimmer Biomet
Biomet France SARL

Terminated

S.E.S Shoulder Arthroplasty Data Collection

Arthritis

France, Belgium
Bioness Inc

Recruiting

StimRouter Registry Clinical Protocol

Nervous System Diseases | Chronic Pain | Peripheral Nervous System Diseases | Peripheral Neuropathy | Peripheral Nerve Injuries | Peripheral Nervous System Problem | Peripheral Nervous

United States
BioCryst Pharmaceuticals

Terminated

A Long Term Safety Study of BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria | PNH

United Kingdom, Austria, South Africa
BioCryst Pharmaceuticals

Terminated

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) (RENEW)

Immunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 Glomerulopathy

France, Italy, Spain, United Kingdom
BioCryst Pharmaceuticals

Active, not recruiting

Long-term Safety of BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

United Kingdom, Hungary, France, Spain, Malaysia, South Africa, Korea, Republic of
BioCryst Pharmaceuticals

Completed

A Long Term Safety Study of BCX7353 in Hereditary Angioedema (APeX-S)

Hereditary Angioedema | Prophylaxis | HAE

Austria, Denmark, France, Germany, Hungary, Israel, Italy, North Macedonia, Poland, Switzerland, United Kingdom, United States, Australia, Hong Kong, Korea, Republic of, New Zealand, Serbia, Slovakia, South Africa, Spain
BioCryst Pharmaceuticals

Terminated

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Influenza

United States
Bioness Inc

Unknown

Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial

Overactive Bladder

United States, Canada
Bioness Inc

Terminated

StimRouter™ for Pain Management in Post-stroke Shoulder Pain (PSSP)

Chronic Pain | Hemiplegic Shoulder Pain

United States
BioCryst Pharmaceuticals

Terminated

Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema (OPuS-4)

Hereditary Angioedema | HAE

France, Belgium
BioCryst Pharmaceuticals

Completed

Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.

Influenza

United States, Canada
BioCryst Pharmaceuticals

Completed

Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE (OPuS-1)

Hereditary Angioedema

Germany, United Kingdom
BioCryst Pharmaceuticals

Completed

A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

Hereditary Angioedema

United Kingdom
BioCryst Pharmaceuticals

Completed

Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol

Arthritis | Hyperuricemia | Gout | Joint Disease

United States
BioCryst Pharmaceuticals

Completed

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

Gout

United States
BioCryst Pharmaceuticals

Completed

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

B-cell Acute Lymphoblastic Leukemia

United States
BioCryst Pharmaceuticals

Completed

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

Lymphoma | Leukemia, Lymphocytic

United States
Biomet Orthopedics, LLC

Completed

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

Osteoarthritis | Avascular Necrosis

United States
Zimmer Biomet
Biomet France SARL

Terminated

TESS Shoulder Arthroplasty Data Collection

Arthritis

France, Belgium
Biomet Orthopedics, LLC

Completed

A Clinical Investigation of the Discovery™ Elbow System

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Humeral Fractures

United States
Biomet Orthopedics, LLC

Terminated

Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia

Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis

United States
Biomet Orthopedics, LLC

Completed

A Clinical Investigation of the Taperloc® Microplasty™ Hip System

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis

United States
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the M2a- Taper™ Hip System

Osteoarthritis | Avascular Necrosis | Non-inflammatory Degenerative Joint Disease
Biomet Orthopedics, LLC

Withdrawn

A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty

Arthritis | Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis
Biomet Orthopedics, LLC

Terminated

ExploR® Modular Radial Head Data Collection

Degenerative Conditions of the Radial Head/Neck | Post-traumatic Conditions of the Radial Head/Neck

United States
Biomet Orthopedics, LLC

Withdrawn

A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Humeral Fractures
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the Copeland™ Humeral Resurfacing Head

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Humeral Fractures
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the M2a-Magnum™ Hip System

Arthritis | Rheumatoid Arthritis | Osteoarthritis, Hip | Joint Disease | Bone Disease
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the M2a- 38™ Hip System

Osteoarthritis | Avascular Necrosis | Non-inflammatory Degenerative Joint Disease
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the Oxford® Partial Knee System

Osteoarthritis
Zimmer Biomet
Biomet France SARL

Completed

Data Collection on ReCap/Magnum in Total Hip Replacement and Resurfacing

Total Hip Resurfacing

France
Biomet Orthopedics, LLC

Terminated

Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement

Osteoarthritis, Hip | Traumatic Arthritis of Hip

United States

Clinical Trials Sponsored by BIOrest Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations